ClinConnect ClinConnect Logo
Search / Trial NCT07020910

Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka

Launched by ZENTRALKLINIK BAD BERKA · Jun 12, 2025

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Arrhythmia

ClinConnect Summary

The Bad Berka Heart Rhythm Registry (2B2R) is a study taking place at the Heart Center Bad Berka. It aims to gather information about patients who have heart rhythm issues, known as arrhythmias, or are at risk for them. This research will help doctors understand how safe different treatments are and how well they work over time. The study will also look at new treatment methods, like pulsed field ablation (PFA), which uses energy to treat heart conditions, and conduction system pacing, which is a way to improve heart beats.

To join this study, participants must be at least 18 years old and either have a diagnosed arrhythmia or be at risk for one, and they should be receiving treatment at the Heart Center Bad Berka. It's important that they are willing to provide informed consent, meaning they agree to participate and understand what it involves. Participants will be monitored to see how they respond to treatment, helping to improve future care for others with similar heart conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥18 years
  • At risk of or with documented cardiac arrhythmia undergoing medical or interventional therapy at the Heart Center Bad Berka
  • Informed consent obtained
  • Exclusion Criteria:
  • Inability or unwillingness to provide informed consent
  • Participation in another interventional trial that precludes registry inclusion

About Zentralklinik Bad Berka

Zentralklinik Bad Berka is a leading healthcare institution in Germany, renowned for its commitment to high-quality patient care and advanced medical research. With a focus on innovative treatment approaches and comprehensive clinical services, the clinic specializes in various medical fields, including rehabilitation and specialized care for chronic conditions. As a dedicated clinical trial sponsor, Zentralklinik Bad Berka actively participates in the development of new therapies and medical technologies, collaborating with academic institutions and industry partners to enhance patient outcomes and contribute to the advancement of medical science. Their rigorous adherence to ethical standards and regulatory compliance underscores their mission to improve healthcare delivery through evidence-based practices.

Locations

Bad Berka, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported